Morgan Stanley’s OSR Health OSRH Stock Holding History

Morgan Stanley’s Portfolio OSRH Stock Details OSRH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-57	Closed	-$79	–	8439
2025 Q2	$79	Buy	57 +2	+4%	+$3	﹤0.01%	7685
2025 Q1	$103	Buy	+55	New	+$302	﹤0.01%	7564

Other funds holding OSRH

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley's OSRH Position: Q3 2025 in Review

Morgan Stanley sold out of OSR Health (OSRH) in Q3 2025, closing a stake of 57 shares — an estimated $79 sold.

Morgan Stanley first reported a position in OSRH in Q1 2025 and held it in 2 quarters. The position peaked at $103 in Q1 2025. 8 funds tracked by Wall St. Rank hold OSRH as of Q3 2025.

Morgan Stanley reported no remaining OSR Health position as of Q3 2025 after selling out during the quarter.
Morgan Stanley sold 57 OSR Health shares in Q3 2025, an estimated $79.
Morgan Stanley first reported a position in OSR Health in Q1 2025 and held it in 2 quarters.
Morgan Stanley's OSR Health position peaked at $103 in Q1 2025.
8 funds tracked by Wall St. Rank held OSR Health as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.